1. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future. Report of a Workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 2004; 109: 951–7.
2. Gastaut H, Tassarini C, Duron B. Etudes polygraphiques des manifestations episodique (hypnique et respiratoire) du syndrome de Pickwick. Rev Neurol 1965; 112: 56–79.
3. Jung R, Kuhlo W. Neuropsychological studies of abnormal night sleep and the Pickwickian syndrome. Prog Brain Res 1965; 18: 140–59.
4. McGregor MI, Block AJ, Ball WS. Serious complications and sudden death in the Pickwickian syndrome. Johns Hopkins Med J 1970; 126–7: 279–95.
5. Guilleminault C, Eldridge F, Dement WC. Insomnia with sleep apnea: a new syndrome. Science 1973; 181, 856–8.
6. Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21 (7): 701–6.
7. Phillipson EA. Wake up, America. A Report of the National Commission on Sleep Disorders Research, 1993.
8. Lugaresi E, Cirignotta F, Coccagna G, Piana C. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980; 3 (3–4): 221–4.
9. Lavie P, Ben-Yosef R, Rubin A.E. Prevalence of sleep apnea among patients with essential hypertension. Am Heart J 1984; 108: 373–6.
10. Waller P, Bhopal RS. Is snoring a cause of vascular disease? Lancet 1989; 1: 143–6.
11. Hla KM, Skatrud JB, Finn L et al. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 2002; 122: 1125–32.
12. Young T, Palta M, Dempsey J et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230–5.
13. Peppard PE, Young T, Palta MP et al. Longitudinal study of moderate weight change and sleep disordered breathing. JAMA 2000; 282: 3015–21.
14. Palmer LJ, Buxbau SG, Larkin EK et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004.
15. Вейн А.М., Елигулашвили Т.С., Полуэктов М.Г. Синдром апноэ во сне. М.: "Эйдос-Медиа", 2002.
16. Лопатин, А.С., Бузунов Р.В., Смушко А.М. и др. Храп и синдром обструктивного апноэ во сне. Рос. ринол. 1998; 4: 17–32.
17. Калинкин А.Л. Синдром обструктивного апноэ сна – фактор риска артериальной гипертензии (обзор). Артериальн. гипертензия 2003; 9: 2: 37–41.
18. Вейн А.М. Медицина сна (лекция). Кремлевская медицина. Клин. вестн. 1998; 5 (дополнит. номер): 70–2.
19. Полуэктов М.Г. Ожирение и сон. В кн.: Ожирение. Под ред. И.И. Дедова и Г.А. Мельниченко. М.: Мед. информ. агентство, 2004; 312–29.
20. Hedner J, Ejnell H, Sellgren J et al. Is high and fluctuating muscle-nerve sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 1988; 6 (4): Suppl. 5520–37.
21. Baylor P, Mouton A, Shamoon HH, Goebel P. Increased norepinephrine variability in patients with sleep apnea syndrome. Am J Med 1995; 99: 6, 611–6.
22. Lin CC, Zan KW, Lin CY. Plasma levels of atrial natriuretic factor in moderate to sever obstructive sleep apnea syndrome. Sleep 1993; 16 (1): 37–9.
23. Aardweg van den JG, Karemaker JM. Repetitive apneas induce periodic hypertension in normal subjects through hypoxia. J Appl Physiol 1992; 72 (3): 821–7.
24. Shimizu T, Kogava S, Tashiro T et al. Transient elevations of blood pressure in OSA. In: Home J., ed Sleep '90. Bochum, West Germany: Pontenagel; 1990; 182–4.
25. Deegan PC, McNicolas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J 1995; 8: 1161–78.
26. Douglas NJ. The sleep apnea/hypopnea syndrome and snoring. ABC of sleep disorders. London: BMJ Publishing group, 1993; 19–22.
27. Houvelingen van K.G., van Uffeln R, van Villet ACM. Sleep apnea syndrome (Review). Eur Heart J 1999; 20: 858–66.
28. ASDA. A review: The indications for polysomnography and related procedures. Sleep, 1997; 20 (6): 423–67.
29. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667–89.
30. Downey R 3rd, Perkin RM, MacQuarrie J. Upper airway resistance syndrome: sick, symptomatic but underrecognised. Sleep 1993;16 (7): 620–3.
31. The international classification of sleep disorders: diagnostic and coding manual. Kansas: Allen Press Inc. 1990.
32. Hoffstein V. Blood pressure, snoring, obesity, and nocturnal hypoxaemia. Lancet 1994; 344: 643–5.
33. Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000; 119 (2–3): 189–97.
34. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000; 283 (14): 1829–36.
35. Peppard PE, Young T, Palta M, Scatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 2000; 342 (18): 1378–84.
36. Brooks D, Horner LF, Kozar CL et al. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106–9.
37. Yaseen A, Morgan BJ, Goodman B et al. Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 1999; 87 (2): 689–98.
38. Kaufmann F, Annesi I, Neukirch V et al. The relation between snoring and smoking, body mass index, age, alcohol consumption and respiratory symptoms. Eur Resp J 1989; 2: 599–603.
39. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161 (5): 1423–8.
40. Longstaff M. Mechanisms proposed whereby beta-blockers might worsen obstructive sleep apnoea. Respir Med 1999; 93 (4): 290–4.
41. Pelttari LH, Hietanen EK, Salo TT et al. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998; 3 (Part 1): 272–6.
42. Sullivan CE, Issa FG, Berton-Johnes M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure therapy. Lancet 1981; I: 862–65.
43. Berry RB, Parish JM, Hartse KM. The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. Sleep 2002; 25: 1148–73.
44. Reeves-Hoche MK, Hudgel DW, Meck R et al. A Ross Continuous versus bilevel positive airway pressure for obstructive sleep apnea Am J Respir Crit Care Med 1995; 151 (2): 443–9.
45. Abdenbi F, Chambille B, Escourrou P. Bench testing of auto-adjusting positive airway pressure devices. Eur Respir J 2004; 24: 649–58.
46. Mayer J, Becker H, Brandenburg U et al. Blood pressure and sleep apnea: Results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991; 79: 84–92.
47. Sanner BM, Tepel M, Markmann A, Zidek W. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients in patients with obstructive sleep apnea syndrome. Am J Hypertens 2002; 15: 251–6.
48. Ip MS, Lam KS, Ho C et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000; 118: 580–6.
49. Shimizu K, Chin K, Nakamura T et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002; 57: 429–34.
50. Sanner BM, Kollhosser P, Buechner N et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004; 23 (4): 601–4.
51. B_rgel J, Sanner BM, Keskin F et al. Obstructive sleep apnea and blood pressure. Am J Hyper 2004; 17 (12): 1081–7.
52. White J, Cates C, Wright J. Continuous positive airways pressure for obstructive sleep apnoea (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & S.

И.Е.Чазова, А.Ю.Литвин

Российский кардиологический научно-производственный комплекс Росздрава, 
Институт кардиологии им. А.Л.Мясникова, Москва